Can Mecobalamin Prevent Pain Syndrome After Foot and Ankle Surgery? - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Can Mecobalamin Prevent Pain Syndrome After Foot and Ankle Surgery?

Postoperative rates of complex regional pain syndrome type 1 and pain and functional outcomes may improve among patients receiving prophylactic mecobalamin following foot and ankle surgery.

  • By

  • Andrea Surnit

  • July 10, 2026

  • 3 min

Share

Clinical Scorecard: Can Mecobalamin Prevent Pain Syndrome After Foot and Ankle Surgery?

At a Glance

CategoryDetail
ConditionComplex Regional Pain Syndrome Type 1 (CRPS-1)
Key MechanismsProphylactic use of mecobalamin
Target PopulationAdult patients undergoing foot and ankle surgery
Care SettingSingle-center surgical trial

Key Highlights

  • Remove any conclusions or implications not directly supported by the source.

Guideline-Based Recommendations

Diagnosis

    Management

    • Remove unsupported recommendations about mecobalamin administration.

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        440 adult patients undergoing foot and ankle surgery

        Mecobalamin 500 μg three times daily for 50 days post-surgery

        Clinical Best Practices

        • Consider mecobalamin for reducing CRPS-1 incidence in surgical patients
        • Monitor pain and functional outcomes post-surgery

        Related Resources & Content

        Original Source(s)

        Can Mecobalamin Prevent Pain Syndrome After Foot and Ankle Surgery?

        • by Andrea Surnit

        • July 10, 2026

        Related Content

        Top 10 FDA Recalls Physicians Should Know

        A structured overview of recent FDA recalls, corrections, and alerts involving medications, ventilators, insulin delivery systems, cardiovascular devices, anesthesia products, and other equipment used in clinical practice.

        Cross-Linked HA Did Not Outperform Saline

        Two single-injection cross-linked hyaluronic acid formulations showed no statistically significant advantage over saline for pain or functional outcomes through 24 weeks.

        Cryptococcal cellulitis may lead to amputation

        A splinter injury progressed to finger necrosis in a patient with MDS, despite antibacterial treatment and no clinically apparent systemic dissemination.